RAD News and Press, Rite Aid Corporation From 06/23/22

Another choppy session finished with solid gains on Thursday, as Wall Street continued to stabilize after last week's sharp decline. The Nasdaq led the upswing, rising 1.6%. While the overall market pushed higher, recession fears continued to weigh on certain sectors. This included farm equip...

Image source: The Motley Fool. Rite Aid (NYSE: RAD) Q1 2023 Earnings Call Jun 23, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Rite Aid (RAD) Q1 2023 Earnings Call Transcript

The following slide deck was published by Rite Aid Corporation in conjunction with their 2023 Q1 earnings call. For further details see: Rite Aid Corporation 2023 Q1 - Results - Earnings Call Presentation

Shares of Rite Aid (NYSE: RAD) were looking downright healthy on Thursday as the stock surged by as much as 15.5%. As of 12:05 p.m. ET, the stock was still up by 15.2%. The catalyst that sent the retail drugstore chain soaring was its fiscal 2023 first-quarter financial report, ...

Rite Aid Corporation (RAD) Q1 2023 Results Conference Call June 23, 2022 08:30 AM ET Company Participants Byron Purcell - Investor Relations Heyward Donigan - President & CEO Matt Schroeder - EVP & CFO Andre Persaud - EVP & CRO, Elixir Chris DuPaul - COO, Elixir Conference Call Pa...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Zeedign.com / Shutterstock.com SIGA Technologies (NASDAQ: SIGA ) stock is heading higher on Thursday after the company announced $13 million worth of TPOXX orders . TPOXX is the company’s oral ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Susan Montgomery / Shutterstock.com Rite Aid (NYSE: RAD ) stock is running higher Thursday morning after the company revealed its earnings report for the fiscal first quarter of 2023 . The good news f...

Rite Aid Corp. ( NYSE: RAD ) is expecting its fiscal 2023 net loss to be bigger than previously projected due to impairment charges from closed stores and an increase in interest expenses from rising interest rates. The drug-store chain reported Q1 FY23 net loss of ~$110.2...

Rite Aid press release (NYSE:RAD): Q1 Non-GAAP EPS of -$0.60 beats by $0.10. Revenue of $6.01B (-2.4% Y/Y) beats by $280M. Shares +0.3% PM. FY2023 Outlook: Total revenues are expected to be between $23.6B and $24B vs. prior outlook of $23.1B and $23.5B and consensus of $22.91B; Retail Pharmac...

Retail Comparable Store Prescriptions Increased 0.9 Percent – Comparable Store Non-COVID Acute Prescriptions Increased 11.9 Percent Revenues of $6.01 billion, Compared to Prior Year Revenues of $6.16 billion Net Loss per Share of $2.03, Compared to Prior Year ...